Doctor Rafael Bojalil is a Mexican physician and researcher specializing in immunology and biomedicine. He studied Medicine at the Universidad Autónoma Metropolitana (UAM) Xochimilco Campus, and holds a Master's and Ph.D. in Basic Biomedical Research from the Universidad Nacional Autónoma de México (UNAM). He is a member of the National System of Researchers, the National Academy of Medicine of Mexico, and the Mexican Academy of Sciences.

He has also conducted research in collaboration with the National Institute of Cardiology. He has worked as Head of the Department of Immunology of the Instituto Nacional de Cardiología Ignacio Chávez, Deputy Director of Planning and Evaluation of CONACyT, and in charge of the Department of Health Care (DAS) of the UAM Xochimilco Campus. He is Full Research Professor Level C in that Department and Director of Research Support at UAM.

In recent years, he has researched inflammation in chronic degenerative diseases, specifically in heart and autoimmune diseases. Some of his lines of research are:

• Inflammation in chronic degenerative diseases, specifically in heart disease and autoimmune diseases.
• The effectiveness and safety of myocardial revascularization by extracorporeal shock waves in patients with refractory angina pectoris and heart failure.
• The immune response to Covid-19 and its complications.

He has also worked on sepsis, autoimmune diseases, coronary artery disease, aortic valve disease, heart failure, and neurodevelopmental immunology. He has graduated more than ten doctors of science; most of them have reached levels II and III of the National System of Researchers. His publications have more than 1900 citations, and he is a privileged observer of how the Covid-19 phenomenon has affected us due to his training and career as an immunologist.